The Current and Future State of the Indian Pharmaceuticals Industry

India’s pharmaceuticals industry is growing at a very fast pace. At present, this industry is the second largest growing industry within India, and in terms of size, it is the third largest in the world, crossing the US$20 billion threshold by the year 2015. Having said so, the industry is also curr...

Full description

Bibliographic Details
Main Author: Osman Kassam, Mohamed Zahir
Format: Dissertation (University of Nottingham only)
Language:English
Published: 2010
Online Access:https://eprints.nottingham.ac.uk/23845/
_version_ 1848792644406214656
author Osman Kassam, Mohamed Zahir
author_facet Osman Kassam, Mohamed Zahir
author_sort Osman Kassam, Mohamed Zahir
building Nottingham Research Data Repository
collection Online Access
description India’s pharmaceuticals industry is growing at a very fast pace. At present, this industry is the second largest growing industry within India, and in terms of size, it is the third largest in the world, crossing the US$20 billion threshold by the year 2015. Having said so, the industry is also currently in a transition phase from process re-engineering (duplication of patented generic drugs) to new product research and development. This paper examines the current state of the industry as well as key future trends. Strengths and weaknesses of the industry are outlined, and potential risks to the industry are identified as well.
first_indexed 2025-11-14T18:47:41Z
format Dissertation (University of Nottingham only)
id nottingham-23845
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T18:47:41Z
publishDate 2010
recordtype eprints
repository_type Digital Repository
spelling nottingham-238452022-03-21T16:07:46Z https://eprints.nottingham.ac.uk/23845/ The Current and Future State of the Indian Pharmaceuticals Industry Osman Kassam, Mohamed Zahir India’s pharmaceuticals industry is growing at a very fast pace. At present, this industry is the second largest growing industry within India, and in terms of size, it is the third largest in the world, crossing the US$20 billion threshold by the year 2015. Having said so, the industry is also currently in a transition phase from process re-engineering (duplication of patented generic drugs) to new product research and development. This paper examines the current state of the industry as well as key future trends. Strengths and weaknesses of the industry are outlined, and potential risks to the industry are identified as well. 2010-12-08 Dissertation (University of Nottingham only) NonPeerReviewed application/pdf en https://eprints.nottingham.ac.uk/23845/1/Individual.pdf Osman Kassam, Mohamed Zahir (2010) The Current and Future State of the Indian Pharmaceuticals Industry. [Dissertation (University of Nottingham only)] (Unpublished)
spellingShingle Osman Kassam, Mohamed Zahir
The Current and Future State of the Indian Pharmaceuticals Industry
title The Current and Future State of the Indian Pharmaceuticals Industry
title_full The Current and Future State of the Indian Pharmaceuticals Industry
title_fullStr The Current and Future State of the Indian Pharmaceuticals Industry
title_full_unstemmed The Current and Future State of the Indian Pharmaceuticals Industry
title_short The Current and Future State of the Indian Pharmaceuticals Industry
title_sort current and future state of the indian pharmaceuticals industry
url https://eprints.nottingham.ac.uk/23845/